Charles Vega, MD: The Primary Care Role in Obesity
Drugs like semaglutide are able to treat both diabetes and obesity.
Rajeev Raghavan, MD, Discusses Updated ADA Guidelines for Diabetic Kidney Disease
Expert nephrologist Dr. Rajeev Raghavan elaborates on the American Diabetes Association guideline updates for patients with diabetic kidney disease during Pri-Med West.
Rajeev Raghavan, MD: SGLT2 Inhibitors and GLP-1 Receptor Agonists
Dr. Rajeev Raghavan talks about the role of SGLT2 inhibitors and GLP-1 receptor agonists as new therapeutics available to slow progression of chronic kidney disease.
Rajeev Raghavan, MD, Talks About the Underutilized Therapeutics in Nephrology
Pri-Med West presenter Dr. Rajeev Raghavan highlights the key points of his nephrology talk and identifies trending topics in the field during an interview.
Proliferative Diabetic Retinopathy Interventions Show Decreased Odds of Anxiety, Depression
These data further elucidate the relationship between mental health and diabetic retinopathy.
Semaglutide Not Associated with Worsening of Diabetic Retinopathy Progression
The study agent was otherwise not associated with an increased number of intravitreal injections over a 12-month period.
Dopamine Treatment May Delay Onset of Diabetic Retinopathy
New research found veterans with diabetes who took L-DOPA and dopamine agonists showed delayed onset of vascular pathology associated with DR.
Tirzepatide Achieved Greater Weight Reduction than Placebo in Patients with Obesity
Participants with obesity or overweight lost up to 22.5% of their body weight with tirzepatide treatment.
Tirzepatide Shows Significant Reduction in Liver Fat Content in Patients with T2D
The absolute reduction in LFC at week 52 was significantly greater for the pooled tirzepatide 10 mg and 15 mg groups versus the insulin degludec group.
Tirzepatide Superior to Insulin Degludec in Achieving T2D Glycemic Targets
Participants assigned to once-weekly tirzepatide spent significantly more time in tight target range at 52 weeks compared with those assigned to insulin degludec.
Cost of Intravitreal Injections for DME May Vary By Treatment Modality
Dexamethasone as a first-line treatment for DME may increase economic costs in settings where bevacizumab is used off-label, but lower annual costs compared with aflibercept.
Racial and Rural Disparities Observed in Diabetic Foot Ulcer Care
Rural patients identifying as Black had a more than 10% absolute increased risk of major leg amputation or death compared with the overall cohort with diabetic foot ulcers.
Biomarker Goal Attainment Improves Life Expectancy in Patients with Type 2 Diabetes
Patients from the lowest BMI, HbA1c, SBP, and LDL-C population quartile had 3.9, 3.8, 1.9, and 0.9 years of additional life expectancy, respectively.
New Research Explores Diabetes Progression Rate in Older Adults with Prediabetes
The estimated annual progression rate to diabetes in older adults with HbA1c-defined prediabetes was 5.3%.
Maternal Autoimmune Disease Linked to Higher Risk of Mental Disorders in Offspring
Infants born to mothers with autoimmune disease had a 16% higher risk of being diagnosed with a mental disorder compared with those who were not prenatally exposed to maternal autoimmune diseases.
High Rate of Diabetic Retinopathy Observed in Pregnant Women with Diabetes
Pregnant women with preexisting T1D or T2D had a higher rate of any DR and a higher DR progression rate compared to the nonpregnant population.
Frequency of Adverse Pregnancy Outcomes Saw Increase Among Patients with Gestational Diabetes
From 2014 to 2020, there was significant increase in the frequency of preeclampsia or gestational hypertension, transfusion, preterm birth <37 weeks, and NICU admission.
Triple Combination Pill Shows Substantial Increase in Time at Target Blood Pressure
The higher time at BP target ranged from 64% in the triple pill group to 43% in the usual care group
Fenofibrate Use May Reduce Progression to Vision-Threatening Diabetic Retinopathy
The study shows fenofibrate use was associated with a lower risk of progression to PDR and VTDR, but not DME alone.
Subcutaneous Insulin Protocol for DKA Shows Significant Decrease in ICU Need
The protocol appeared safe, with no associated increases in the incidence of hypoglycemic events during hospitalization or 30-day mortality.
Miriam Vos, MD: Studying Pediatric Patients With NAFLD
The prevalence of NAFLD in the pediatric population has increased in recent years.
A Preview of the Ziltevekimab ZEUS Clinical Trial
Study co-chair Paul Ridker, MD, shares details behind the new global assessment of the IL-6 inhibitor for patients with atherosclerosis and CKD.
Javed Butler, MD: Consistent Benefits of Finerenone On CV, Kidney Outcomes
Dr. Butler discusses findings from the FIDELITY analyses on the consistent benefits of finerenone, regardless of ASCVD history in patients with CKD and T2D.
How Findings from SuperWIN May Shape the Future of Dietary Education
A discussion into broadening the findings of the SuperWIN trial and its potential effects on a larger, more at-risk population.
SuperWIN Nutrition Education in Grocery Stores Linked To Improved Dietary Quality
Dylan Steen, MD discusses positive findings from the trial on links between personalized education and DASH diet adherence.
Sotagliflozin Reduces MACE Risk in Diabetic, Kidney Disease Patients in SCORED Trial
Study author Deepak L. Bhatt, MD, MPH, discusses the unique SGLT-1 and SGLT-2 inhibition derived from sotagliflozin, and how impactful its benefit may be.
Barbara Simon, MD: Advances in Insulin for Diabetic Patients
There are now more insulin options for patients with diabetes than ever before.
Serge Jabbour, MD: The Current Landscape of Diabetes Care
Dr. Jabbour discusses unmet needs in diabetes care and starting insulin therapy.
Team-Based Care Reduces Risk in Patients with Diabetic Kidney Disease
Team-based care shows the reduction of multiple risk factors, attainment of multiple treatment targets, and empowerment among high-risk patients with DKD.
FDA Approves Oral Treatment For Testosterone Replacement Therapy
The therapy is indicated for conditions associated with hypogonadism in adult males.
2 Clarke Drive Cranbury, NJ 08512